Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Hoepp

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Research in Veterinary Science|December 31, 2020
Pathology of macrophage activation syndrome in humanized NSGS miceJames C Tarrant, Zev A Binder, Mattia Bugatti, et al.
Veterinary Clinical Pathology|January 6, 2026
Digital Cytopathology Quality GuidelinesEric J Fish, Natalie Hoepp, Jennifer R Matlow, et al.
Regulatory Toxicology and Pharmacology : RTP|April 28, 2024
Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studiesXavier Palazzi, Lennart T Anger, Theresa Boulineau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2021
Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathiesLaura Breda, Valentina Ghiaccio, Naoto Tanaka, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Research in Veterinary Science|December 31, 2020
Pathology of macrophage activation syndrome in humanized NSGS miceJames C Tarrant, Zev A Binder, Mattia Bugatti, et al.
Veterinary Clinical Pathology|January 6, 2026
Digital Cytopathology Quality GuidelinesEric J Fish, Natalie Hoepp, Jennifer R Matlow, et al.
Regulatory Toxicology and Pharmacology : RTP|April 28, 2024
Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studiesXavier Palazzi, Lennart T Anger, Theresa Boulineau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 30, 2021
Lentiviral vector ALS20 yields high hemoglobin levels with low genomic integrations for treatment of beta-globinopathiesLaura Breda, Valentina Ghiaccio, Naoto Tanaka, et al.
Pageof 1